References
- Cho, M.-H., Paik, Y.-S., and Hahn, T.-R., Propionylshikonin rom the roots of Lithospermum erythrorhizon. Arch. Pharm. Res., 22, 414-416 (1999) https://doi.org/10.1007/BF02979068
- Chung, M.-S. and Lee, M.-S., Stability and sensory evaluation of naphtoquinone pigments from the roots of Lithospermum erythrorhizon. Korean J. Food Sci. Technol., 26, 152-156 (1994)
- Doll, R.J., Kirschmeier, P., and Bishop, W.R., Farnesyltransferase inhibitors as anticancer agents: Critical crossroads. Curr. Opin. Drug Discov. Devel. 7, 478-486 (2004)
- Gibbs, J.B., Anticancer drug targets: growth factors and growth factor signaling. J. Clin. Invest. 105, 9-13 (2000) https://doi.org/10.1172/JCI9084
- Gibbs, J.B., Oliff, A., and Kohl, N.E., Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. Cell 77, 175-178 (1994) https://doi.org/10.1016/0092-8674(94)90308-5
- Gibbs, J.B., Pompliano, D.L., Mosser, S.D., Rands, E., Lingham, R.B., Singh, S.B., Scolnick, E.M., Kohl, N.E., and Oliff, A., Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo. J. Biol. Chem. 268, 7617-7620 (1993)
- Hwang, S.Y., Hwang, B.Y., Kang, S.S., Kim, C.M., Park, J.H., Bae K.H., Son, K.H., Lee, S.H., and Chang, S.Y., Isolation and quantitative analysis of acetylshikonin from Lithospermi Radix. Kor. J. Pharmacogn. 31, 295-299 (2000)
- Inoue, K., Akaji, M., and Inouye, H., Quinones and related compounds in higher plants. XXI. New findings on the proton and carbon-13 nuclear magnetic resonance spectra of shikonin. Chem. Pharm. Bull. 33, 3993- 3997 (1985) https://doi.org/10.1248/cpb.33.3993
- Kim, H. and Ahn, B.-Z., Antitumor effects of acetylshikonin and some synthesized naphtharazin on L1210 and S-180 system. Yakhak Hoeji 34, 262-266 (1990)
- Kimura, T., But, P.P.H., Guo, J.-X., and Sung, C.K., International collation of traditional an folk medicine. Part I, World Scientific, Singapore, p. 137-138 (1996)
- Kohl, N.E., Wilson, F.R., Mosser, S.D., Giulani, E.A., De Solms, S.J., Conner, M.W., Anthony, N.J., Holtz, W.J., Gomez, R.P., Lee, T.J., Smith, R.L., Hartman, G.D., Gibbs, J.B., and Oliff, A., Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice. Proc. Natl. Acad. Sci. USA. 91, 9141-9145 (1994)
- Kundakovic, T., Fokialakis, N., Dobric, S., Pratsinis, H., Kletsas, D., Kovacevic, N., and Chinou, I., Evaluation of the anti-inflammatory and cytotoxic activities of naphthazarine derivatives from Onosma leptantha. Phytomed. 13, 290-294 (2006) https://doi.org/10.1016/j.phymed.2004.10.009
- Lee, J.-H. And Ahn, B.-Z., Antineoplastic natural products and the analogues (Xi); Cytotoxsic activity against L1210 cells of some raw drugs from the Oriental medicine and folklore. Kor. J. Pharmacogn. 17, 286-291 (1986)
- Lee, S.H., Kim, H.K, Kang, H.M., Seo, J.M., Son, K.H., Lee, H.S., and Kwon, B.M., Arteminolides B, C and D, new inhibitors of farnesyl protein transferase from Artemisia argyi. J. Org. Chem. 67, 7670-7675 (2002) https://doi.org/10.1021/jo020299z
- Lowy, D.R. and Willumsen, B.M., Function and regulation of Ras. Annu. Rev. Biochem. 62, 851-891 (1993) https://doi.org/10.1146/annurev.bi.62.070193.004223
- Morimoto, I. and Hirat, Y., New naphthoquinone derivatives from Lithospermum erythrorhizon. Tetrahedron Lett. 3677-3680 (1966)
- Morimoto, I., Kishi, T., Ikegami, S., and Hirata, Y., Naphtohquinone derivatives from Lithospermum erythrorhizon Siebold et Zuccarint. Tetrahedron Lett. 4737-4739 (1965)
- Oliff. A., Farnesyltransferase inhibitors: targeting the molecular basis of cancer. Biochim. Biophys. Acat 1423, C19-C30 (1999)
- Oh, H.-M., Choi, S.-K., Lee, J. M., Lee, S.-K., Kim, H.-Y., Han, D.C., Kim, H.-M., Son, K.-H., and Kwon, B.-M., Cyclopentenediones, inhibitors of farnesyl protein transferase and anti-tumor compounds, isolated from the fruit of Lindera erythrocarpa Makino. Bioorg. Med. Chem. 13, 6182-6187 (2005) https://doi.org/10.1016/j.bmc.2005.06.029
- Oh, H.M., Kwon, B.M., Baek, N.I., Kim, S.H., Chung, I.S., Park, M.H., Park, H.W., Lee, J.H., Park, H.W., Kim, E.J., and Kim, D.K., Inhibitory activity of isorhamnetin from Persicaria thunbergii on farnesyl protein transferase. Arch. Pharm. Res. 28, 169-171 (2005) https://doi.org/10.1007/BF02977709
- Omer, C.A., Chen, Z., Diehl, R.E., Conner, M.W., Chen, H.Y., Trumbauer, M.E., Gopal-Truter, S., Seeburger, G., Bhimnathwala, H., Abrams, M.T., Davide, J.P., Ellis, M.S., Gibbs, J.B., Greenberg, I., Koblan, K.S., Kral, A.M., Liu, D., Lobell, R.B., Miller, P.J., Mosser, S.D., O'Neill, T.J., Rands, E., Schaber, M.D., Senderak, E.T., Oliff, A., and Kohl, N.E., Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor. Cancer Res. 60, 2680-2688 (2000)
- Reiss, Y., Goldstein, J.L., Seabra, M.C., Casey, P.J., and Brown, M.S., Inhibition of purified p21 Ras farnesyl protein transferase by Cys- AAX tetrapeptides. Cell 62, 81-88 (1990) https://doi.org/10.1016/0092-8674(90)90242-7
- Sepp-Lorenzino, L., Tjaden, G., Moasser, M.M., Timaul, N., Ma, Z., Kohl, N.E., Gibbs, J.B., Oliff, A., Rosen, N., and Scher, H.I., Farnesyl : protein transferase inhibitors as potential agents for the management of human prostate cancer. Prostate Cancer Prostatic Dis. 4, 33-43 (2001) https://doi.org/10.1038/sj.pcan.4500491
- Suzanne, C. M., S. Jane deSolms, Anthony, W.S., Marc, T.A., Terrence, M.C., Joseph, P.D., Kelly, A.H., John, H.H., Kenneth, S.K., Nancy, E.K., Robert, B.L., Ronald, G.R., and Samuel, L.G., Diaryl ether inhibitors of farnesyl-protein transferase. Bioorg. Med. Chem. Lett. 11, 1257-1260 (2001) https://doi.org/10.1016/S0960-894X(01)00162-7
- Tanaka, S., Tajima, M., Tsukada, M., and Tabata, M., A comparative study on anti-inflammatory activities of the enantiomers, shikonin and alkannin. J. Nat. Prod. 49, 466-469 (1986) https://doi.org/10.1021/np50045a014